Researchers create better yardstick for GVHD treatment success
NCT ID NCT01902576
Summary
This study aims to develop better tools to measure whether treatments are working for chronic Graft-versus-Host Disease (GVHD), a serious complication that can occur after stem cell transplants. Researchers are following 383 patients who have started new treatments for chronic GVHD to create more accurate ways to track their response. The goal is to help doctors better predict which treatments will work for which patients in future clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT VS HOST DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.